Question-and-Answer Session
Operator
(Operator Instructions) Your first question comes from the line of Tycho Peterson – JPMorgan
Tycho Peterson – JPMorgan
On NovaSure, can you give us a sense as to how sustainable some of trends that you’re seeing are. I know you talked about a modest quarter over quarter decline in this coming quarter but can you give a sense of what some of the market dynamics are like for NovaSure today.
Tony Kingsley
Market trends are quite positive on NovaSure. We did indeed have a very good quarter. We do believe that our strategy focused on driving procedures is gaining traction. A couple of things have not changed, we still think the condition is undertreated and there’s a big potential market there. Our competitive position if anything has improved based on some recent clinical data. We don’t [inaudible] completely immune, obviously to the economy we have not seen any signs of a decline in procedure volume yet and its not fundamentally changed our outlook at the US for the full year.
It is as you know not an elective procedure but its certainly deferrable. So we do expect to see as we typically do in the second fiscal quarter a bigger challenge because the economics particularly around patient deductibles.
Tycho Peterson – JPMorgan
Can you give us a sense if there are any dynamics in terms of configuration issues. I know you’ve talked in the past about some of the configuration changes you’ve seen. Can you give us a sense as to what you’re seeing in the current environment.
Robert Cascella
Yes, we are seeing a move to lower end units, our remanufactured units as well as our screening units domestically or in the US market. Its not to say that we’re not selling standard Selenia’s but the drive has been much more about a product mix change relative to low end units that are now being sold to single user sites.
Outside the United States it’s a bit of business as usual with the exception that we are certainly selling higher end products like our dimension tomosynthesis product.
Operator
Your next question comes from the line of David Lewis – Morgan Stanley
David Lewis – Morgan Stanley
I wanted to focus on guidance, you’re saying that guidance essentially implies that things are going to get worse, I’m trying to get a sense of the magnitude of that. If we look at your guidance for the next quarter it implies an $80 million change to guidance, you’re obviously changing it by a much more substantial degree. Are you saying you’re changing things to reflect an environment that’s much worse then what you’ve seen December, much worse then you’ve seen in January and much worse then backlog would assume.
- To read the full transcript on Seeking Alpha, click here »
